Contact
Please use this form to send email to PR contact of this press release:
Regeneron and Sanofi Provide Update on Dupixent® (dupilumab) sBLA for Chronic Spontaneous Urticaria
TO:
Please use this form to send email to PR contact of this press release:
Regeneron and Sanofi Provide Update on Dupixent® (dupilumab) sBLA for Chronic Spontaneous Urticaria
TO: